Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2010, Vol. 15 ›› Issue (2): 175-179.

Previous Articles     Next Articles

UPLC/Q-TOFMS determination of muscone in plasma of rat administrated by artificial-musk

LENG Yu-jing1, LI Hai-tao1,2, DENG Hai-shan1   

  1. 1 College of Pharmacy, Nanjing University of Traditional Chinese Medicine, Nanjing 210046,Jiangsu,China;
    2 College of traditional Chinese Medicine, Macao University of Science and Technology, Macao 00853, China;
    3 Department of Pharmaceutical analysis, Nanjing University of Traditional Chinese Mdeicine, Nanjing 210046, Jiangsu, China
  • Received:2009-10-29 Revised:2009-12-23 Online:2010-02-26 Published:2020-09-18

Abstract: AIM: To develop a method for the determination of muscone in plasma of the rat administered by artificial-musk. METHODS: Sample was prepared by liquid-liquid extraction,which was chromatographed on ACQUITY UPLC/Q-TOFMS with a ACQUITY UPLC BEH C18(2.1 mm×100 mm,1.7 μm)column at 35 ℃. The mobile phase was 85% acetonitrile with 0.1% formic acid-15% 0.1%FA at the flow rate of 0.2 mL/min. APCI ion source was used and data was collected at positive ion mode. RESULTS: A good linear relationship was obtained between the peak area ratio of muscone(R=0.9980) and the concentration of muscone over the range of 0.0756 to 3.78 μg/mL. The limit of quantitation was 0.05 μg/mL. Accuracy and precision of all concentrations meet the biological sample testing requirements(RE<10%,RSD<15%). Average absolute recovery was bigger than 81%. CONCLUSION: The method was reliable, stable, special and suitable for the study of preclinical pharmacokinetics of artificial-musk.

Key words: Artificial-musk, Muscone, UPLC/Q-TOFMS, Pharmacokinetics

CLC Number: